Cited by 1,271Alcohol Consumption and Health EffectsLiver Disease Diagnosis and TreatmentLiver Disease and Transplantation

The DOI matches its Crossref record; 242 of the 244 references it cites were found in a registry or an index.

Alcoholic liver disease

Seitz, Helmut K., Bataller, Ramon, Cortez-Pinto, Helena, Gao, Bin, Gual, Antoni, Lackner, Carolin, Mathurin, Philippe, Mueller, Sebastian, Szabo, Gyongyi, Tsukamoto, Hidekazu·2018·Nature Reviews Disease Primers

DOI 10.1038/s41572-018-0014-7

Open this paper in CoChat — free account

Abstract

Alcoholic liver disease (ALD) is the most prevalent type of chronic liver disease worldwide. ALD can progress from alcoholic fatty liver (AFL) to alcoholic steatohepatitis (ASH), which is characterized by hepatic inflammation. Chronic ASH can eventually lead to fibrosis and cirrhosis and in some cases hepatocellular cancer (HCC). In addition, severe ASH (with or without cirrhosis) can lead to alcoholic hepatitis, which is an acute clinical presentation of ALD that is associated with liver failure and high mortality. Most individuals consuming >40 g of alcohol per day develop AFL; however, only a subset of individuals will develop more advanced disease. Genetic, epigenetic and non-genetic factors might explain the considerable interindividual variation in ALD phenotype. The pathogenesis of ALD includes hepatic steatosis, oxidative stress, acetaldehyde-mediated toxicity and cytokine and chemokine-induced inflammation. Diagnosis of ALD involves assessing patients for alcohol use disorder and signs of advanced liver disease. The degree of AFL and liver fibrosis can be determined by ultrasonography, transient elastography, MRI, measurement of serum biomarkers and liver biopsy histology. Alcohol abstinence achieved by psychosomatic intervention is the best treatment for all stages of ALD. In the case of advanced disease such as cirrhosis or HCC, liver transplantation may be required. Thus, new therapies are urgently needed.

Integrity signals

Registry

Crossref · 10.1038/s41572-018-0014-7

Cites

242 of 242 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells
Chen, C., Tsukamoto, H., Liu, J.-C., Kashiwabara, C., Feldman, D. E., Sher, L. S., Dooley, S., French, S. W., Mishra, L., Petrovic, L., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65859 · Cited by 161
Self-citation
Retracted
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820
The AUDIT Alcohol Consumption Questions (AUDIT-C)<subtitle>An Effective Brief Screening Test for Problem Drinking</subtitle>
Bush, K. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1789 · Cited by 6,196
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
Naghavi, M., Abajobir, A. A., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abera, S. F., Aboyans, V., Adetokunboh, O., Afshin, A., Agrawal, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32152-9 · Cited by 4,821
AASLD guidelines for the treatment of hepatocellular carcinoma
Heimbach, J. K., Kulik, L., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., Zhu, A. X., Murad, M. H., & Marrero, J. A. (2017) · Hepatology · doi:10.1002/hep.29086 · Cited by 4,107
Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders
Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60746-7 · Cited by 3,870
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219

Show all 244 references

Research works printed but not linked: 4

Pone, E. J. Toll-like receptors. Signal. Pathways Liver Diseases 1390, 149–159 (2016).
French, S. W. & Bardag-Gorce, F. in Signaling Pathways in Liver Diseases (eds Dufour, J.-F. et al.) 377–389 (Springer, 2005).
Thiele, M. et al. Controlled attenuation parameter and alcoholic hepatic steatosis: diagnostic accuracy and role of alcohol detoxification. J. Hepatol. 68, 1025–1032 (2018). · DOI
[No authors listed.]. Alcoholic liver disease: morphological manifestations. Review by an international group. Lancet 1, 707–711 (1981).

Sorted by citations

Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases
Crabb, D. W., Im, G. Y., Szabó, G., Mellinger, J. L., & Lucey, M. R. (2019) · Hepatology · doi:10.1002/hep.30866 · Cited by 938
Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer
Huang, D. Q., Singal, A. G., Kono, Y., Tan, D. J. H., El‐Serag, H. B., & Loomba, R. S. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.05.003 · Cited by 557
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
Huang, D. Q., Mathurin, P., Cortez-Pinto, H., & Loomba, R. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00688-6 · Cited by 553
Self-citation
Gut microbiome, liver immunology, and liver diseases
Wang, R., Tang, R., Li, B., Ma, X., Schnabl, B., & Tilg, H. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00592-6 · Cited by 466
Health Benefits and Side Effects of Short-Chain Fatty Acids
Xiong, R.-G., Zhou, D.-D., Wu, S.-X., Huang, S., Saimaiti, A., Yang, Z., Shang, A., Zhao, C., Gan, R., & Li, H. (2022) · Foods · doi:10.3390/foods11182863 · Cited by 507
Mitochondrial alterations in fatty liver diseases
Fromenty, B., & Roden, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.09.020 · Cited by 448
Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury
Rungratanawanich, W., Qu, Y., Wang, X., Essa, M. M., & Song, B.-J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00561-7 · Cited by 411
Hepatocellular carcinoma in the setting of alcohol-related liver disease
Ganne-Carrié, N., & Nahon, P. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.008 · Cited by 360
Alcohol-associated liver disease
Mackowiak, B., Fu, Y., Maccioni, L., & Gao, B. (2024) · Journal of Clinical Investigation · doi:10.1172/jci176345 · Cited by 359
Self-citation
The AMPK pathway in fatty liver disease
Fang, C., Pan, J., Qu, N., Lei, Y., Han, J., Zhang, J., & Han, D. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.970292 · Cited by 364
Changing epidemiology of hepatocellular carcinoma in Asia
Zhang, C., Cheng, Y., Zhang, S., Fan, J., & Gao, Q. (2022) · Liver International · doi:10.1111/liv.15251 · Cited by 349
Fibrosis and alcohol-related liver disease
Lackner, C., & TINIAKOS, D. G. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.003 · Cited by 326
Self-citation
Liver diseases: epidemiology, causes, trends and predictions
Gan, C., Yuan, Y., Shen, H., Gao, J., Kong, X., Che, Z., Guo, Y., Wang, H., Dong, E., & Xiao, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02072-z · Cited by 416
Beneficial Effects of Betaine: A Comprehensive Review
Arumugam, M. K., Paal, M. C., Donohue, T. M., Ganesan, M., Osna, N. A., & Kharbanda, K. K. (2021) · Biology · doi:10.3390/biology10060456 · Cited by 313
Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease
Wu, X., Fan, X., Miyata, T., Kim, A., Cajigas-Du Ross, C. K., Ray, S., Huang, E., Taiwo, M., Arya, R., Wu, J., et al. (2023) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031521-030435 · Cited by 289
Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis
Lang, S., Duan, Y., Liu, J., Torralba, M., Kuelbs, C., Cots, M. V., Abraldeṣ, J. G., Bosques‐Padilla, F., Verna, E. C., Brown, R. S., et al. (2019) · Hepatology · doi:10.1002/hep.30832 · Cited by 239
Self-citation
Global Burden of Alcohol Use Disorders and Alcohol Liver Disease
Rehm, J. T., & Shield, K. D. (2019) · Biomedicines · doi:10.3390/biomedicines7040099 · Cited by 251
Microbiome-derived ethanol in nonalcoholic fatty liver disease
Meijnikman, A. S., Davids, M., Herrema, H., Aydin, O., Tremaroli, V., Rios-Morales, M., Levels, H., Bruin, S., de Brauw, M., Verheij, J., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02016-6 · Cited by 215
Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting
Avila, M. A., Dufour, J., Gerbes, A. L., Zoulim, F., Bataller, R. A., Burra, P., Cortez‐Pinto, H., Gao, B., Gilmore, I. T., Mathurin, P., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-319720 · Cited by 210
Self-citation
Microbiota tryptophan metabolism induces aryl hydrocarbon receptor activation and improves alcohol-induced liver injury
Wrzosek, L., Ciocan, D. M., Hugot, C., Spatz, M., Dupeux, M., Houron, C., Moal, V. L.-L., Puchois, V., Ferrere, G., Trainel, N., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321565 · Cited by 206
Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease
Aguado, D. M., Calleja, J. L., Vilar‐Gómez, E., Iruzubieta, P., Rodríguez-Duque, J. C., Barrio, M. D., Puchades, L. G., Rivera‐Esteban, J., Perelló, C., Puente, Á., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.06.036 · Cited by 206
Self-citation
Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction
LeFort, K. R., Rungratanawanich, W., & Song, B.-J. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05061-7 · Cited by 202
Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease
Kong, L.-Z., Chandimali, N., Han, Y., Lee, D., Kim, J., Kim, S., Kim, T., Jeong, D. K., Sun, H., Lee, D. S., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112712 · Cited by 205
An Open‐Label, Dose‐Escalation Study to Assess the Safety and Efficacy of IL‐22 Agonist F‐652 in Patients With Alcohol‐associated Hepatitis
Arab, J. P., Sehrawat, T. S., Simonetto, D. A., Verma, V. K., Feng, D., Tang, T., Dreyer, K., Yan, X., Daley, W. L., Sanyal, A. J., et al. (2019) · Hepatology · doi:10.1002/hep.31046 · Cited by 202
Self-citation
Mitochondrial Oxidative Stress and Antioxidants Balance in Fatty Liver Disease
García‐Ruiz, C., & Fernández-Checa, J. C. (2018) · Hepatology Communications · doi:10.1002/hep4.1271 · Cited by 202
Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver Disease
Yang, Y. M., Cho, Y. E., & Hwang, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020774 · Cited by 207
Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology
Huang, D. Q., Singal, A. G., Kanwal, F., Lampertico, P., Buti, M., Sirlin, C. B., Nguyen, M. H., & Loomba, R. S. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00818-8 · Cited by 201
The Nrf2 Pathway in Liver Diseases
Zhou, J., Zheng, Q., & Chen, Z. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.826204 · Cited by 204
Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives
Liu, S.-Y., Tsai, I., & Hsu, Y.-C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105170 · Cited by 186
Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease
Arab, J. P., Díaz, L. A., Rehm, J. T., Im, G. Y., Arrese, M. A., Kamath, P. S., Lucey, M. R., Mellinger, J. L., Thiele, M. S., Thursz, M. R., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.11.028 · Cited by 193
Self-citation
Nicotinamide Mononucleotide: A Promising Molecule for Therapy of Diverse Diseases by Targeting NAD+ Metabolism
Hong, W., Mo, F., Zhang, Z., Huang, M., & Wei, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00246 · Cited by 182
Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease
Yan, C., Hu, W., Tu, J., Li, J., Liang, Q., & Han, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04166-8 · Cited by 195
Lactobacillus plantarum KLDS1.0344 and Lactobacillus acidophilus KLDS1.0901 Mixture Prevents Chronic Alcoholic Liver Injury in Mice by Protecting the Intestinal Barrier and Regulating Gut Microbiota and Liver-Related Pathways
Li, H., Shi, J., Zhao, L. M., Guan, J., Liu, F., Huo, G., & Li, B. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c06346 · Cited by 172
Activity-based fluorescence probes for pathophysiological peroxynitrite fluxes
Mao, Z., Xiong, J., Wang, P., An, J., Zhang, F., Liu, Z., & Kim, J. S. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214356 · Cited by 167
Organoids to model liver disease
Nuciforo, S., & Heim, M. H. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2020.100198 · Cited by 164
ATF4 activation promotes hepatic mitochondrial dysfunction by repressing NRF1–TFAM signalling in alcoholic steatohepatitis
Hao, L., Zhong, W. H., Dong, H., Guo, W., Sun, X., Zhang, W., Yue, R., Li, T., Griffiths, A., Ahmadi, A. R., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321548 · Cited by 168
Alcohol, Inflammation, and Microbiota in Alcoholic Liver Disease
Dukić, M., Radonjić, T., Jovanović, I., Zdravkovic, M. D., Todorović, Z., Kraišnik, N., Aranđelović, B., Mandić, O., Popadić, V., Nikolić, N., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043735 · Cited by 164
Endoplasmic Reticulum Stress in Metabolic Liver Diseases and Hepatic Fibrosis
Maiers, J. L., & Malhi, H. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1681032 · Cited by 151
Metabolic diseases and healthy aging: identifying environmental and behavioral risk factors and promoting public health
Zhang, K., Ma, Y., Luo, Y., Song, Y., Xiong, G., Ma, Y., Sun, X., & Kan, C. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1253506 · Cited by 187
Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment
McQuitty, C. E., Williams, R., Chokshi, S., & Urbani, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.574276 · Cited by 146
Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019
Wu, X., Xue, F., Zhang, N., Zhang, W., Hou, J., Lv, Y., Xiang, J., & Zhang, X. (2024) · BMC Public Health · doi:10.1186/s12889-024-17948-6 · Cited by 146
Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH
Tan, D. J. H., Setiawan, V. W., Ng, C. H., Lim, W. H., Muthiah, M. D., Tan, E. X. X., Dan, Y. Y., Roberts, L. R., Loomba, R. S., & Huang, D. Q. (2022) · Hepatology · doi:10.1002/hep.32758 · Cited by 148
The epigenetic regulator SIRT6 protects the liver from alcohol-induced tissue injury by reducing oxidative stress in mice
Kim, H.-G., Huang, M., Yue, X., Zhang, Y., Zhang, X., Wang, G., Liu, S., Wan, J., Ahmadi, A. R., Sun, Z., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.019 · Cited by 137
Oxidative Stress–Induced Liver Damage and Remodeling of the Liver Vasculature
Banerjee, P., Gaddam, N., Chandler, V., & Chakraborty, S. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.06.002 · Cited by 147
Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy
Subramaniyan, V., Chakravarthi, S., Jegasothy, R., Wu, Y. S., Fuloria, N. K., Fuloria, S., Hazarika, I., & Das, A. (2021) · Toxicology Reports · doi:10.1016/j.toxrep.2021.02.010 · Cited by 138
Danger signals in liver injury and restoration of homeostasis
Han, H., Desert, R., Das, S., Song, Z., Athavale, D., Ge, X., & Nieto, N. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.033 · Cited by 127
Supervised Machine Learning Models for Liver Disease Risk Prediction
Dritsas, E., & Τρίγκα, Μ. (2023) · Computers · doi:10.3390/computers12010019 · Cited by 138
Structural elucidation of an active polysaccharide from Radix Puerariae lobatae and its protection against acute alcoholic liver disease
Cao, W., Wu, J., Zhao, X., Li, Z., Yu, J., Shao, T., Hou, X., Zhou, L., Wang, C., Wang, G., et al. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.121565 · Cited by 123
Mitochondria as the Target of Hepatotoxicity and Drug-Induced Liver Injury: Molecular Mechanisms and Detection Methods
Mihajlovic, M., & Vinken, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063315 · Cited by 132
Cell pyroptosis in health and inflammatory diseases
Wu, Y., Zhang, J., Yu, S., Li, Y., Zhu, J., Zhang, K., & Zhang, R. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00998-3 · Cited by 125
Dietary fiber alleviates alcoholic liver injury via Bacteroides acidifaciens and subsequent ammonia detoxification
Shen, H., Zhou, L., Zhang, H., Yang, Y., Jiang, L., Wu, D., Shu, H., Zhang, H., Xie, L., Zhou, K., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.06.008 · Cited by 125
Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside
Yin, Y., Feng, W., Chen, J., Chen, X., Wang, G., Wang, S., Xu, X., Nie, Y., Fan, D., Wu, K., et al. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00539-x · Cited by 122
Alcohol’s Impact on the Gut and Liver
Pohl, K., Moodley, P., & Dhanda, A. (2021) · Nutrients · doi:10.3390/nu13093170 · Cited by 110
Iron overload in alcoholic liver disease: underlying mechanisms, detrimental effects, and potential therapeutic targets
Li, L.-X., Guo, F., Liu, H., & Zeng, T. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04239-9 · Cited by 113
Noncancerous disease-targeting AIEgens
Duo, Y., Luo, G., Zhang, W., Wang, R., Xiao, G. G., Li, Z., Li, X., Chen, M., Yoon, J., & Tang, B. Z. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00610c · Cited by 106
Cellular plasticity balances the metabolic and proliferation dynamics of a regenerating liver
Chembazhi, U. V., Bangru, S., Hernaez, M., & Kalsotra, A. (2021) · Genome Research · doi:10.1101/gr.267013.120 · Cited by 102
Animal and Organoid Models of Liver Fibrosis
Bao, Y., Wang, L., Pan, H., Zhang, T.-R., Chen, Y., Xu, S.-J., Mao, X., & Li, S.-W. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.666138 · Cited by 101
Lactobacillus plantarum ZY08 relieves chronic alcohol-induced hepatic steatosis and liver injury in mice via restoring intestinal flora homeostasis
Ding, Q., Cao, F., Lai, S., Zhuge, H., Chang, K., Valencak, T. G., Liu, J., Li, S., & Ren, D. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111259 · Cited by 101
Growing burden of alcoholic liver disease in China: A review
Wang, W., Xiao, P., Xu, H., Niu, J., & Gao, Y. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i12.1445 · Cited by 100
Glutamate Signaling in Hepatic Stellate Cells Drives Alcoholic Steatosis
Choi, W., Kim, H., Kim, M., Çınar, R., Yi, H., Eun, H. S., Kim, S., Choi, Y. J., Lee, Y., Kim, S. Y., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.001 · Cited by 98
Self-citation
Alcohol-Associated Tissue Injury: Current Views on Pathophysiological Mechanisms
Simon, L., Souza‐Smith, F. M., & Molina, P. E. (2022) · Annual Review of Physiology · doi:10.1146/annurev-physiol-060821-014008 · Cited by 97
The role of FGF21 and its analogs on liver associated diseases
Falamarzi, K., Malekpour, M., Tafti, M. F., Azarpira, N., Behboodi, M., & Zarei, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.967375 · Cited by 94
Scoparone as a therapeutic drug in liver diseases: Pharmacology, pharmacokinetics and molecular mechanisms of action
Hui, Y., Wang, X., Yu, Z., Fan, X., Cui, B., Zhao, T., Mao, L., Feng, H., Lin, L., Yu, Q., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105170 · Cited by 104
Revitalizing Ancient Mitochondria with Nano‐Strategies: Mitochondria‐Remedying Nanodrugs Concentrate on Disease Control
Long, X., Liu, M., Nan, Y., Chen, Q., Xiao, Z., Xiang, Y., Ying, X., Sun, J., Huang, Q., & Ai, K. (2024) · Advanced Materials · doi:10.1002/adma.202308239 · Cited by 97
Advanced Glycation End Products in Disease Development and Potential Interventions
Zhang, Y., Zhang, Z., Tu, C., Chen, X., & He, R. (2025) · Antioxidants · doi:10.3390/antiox14040492 · Cited by 117
In vivo liver function reserve assessments in alcoholic liver disease by scalable photoacoustic imaging
Sun, T. S., Lv, J., Zhao, X., Li, W., Zhang, Z., & Nie, L. (2023) · Photoacoustics · doi:10.1016/j.pacs.2023.100569 · Cited by 93
The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study
Morales-Arráez, D. E., Cots, M. V., Altamirano, J., Abraldeṣ, J. G., Cruz-Lemini, M., Thursz, M. R., Atkinson, S. R., Sarin, S. K., Kim, W. K., Chavez-Araujo, R., et al. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001596 · Cited by 92
Self-citation
Gut Microbiome and Metabolome Response of Pu-erh Tea on Metabolism Disorder Induced by Chronic Alcohol Consumption
Liu, Y., Luo, Y., Wang, X., Luo, L., Sun, K., & Zeng, L. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c01947 · Cited by 94
Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis
Niu, X., Zhu, L., Xu, Y., Zhang, M., Hao, Y., Ma, L., Li, Y., & Xing, H. (2023) · BMC Public Health · doi:10.1186/s12889-023-15749-x · Cited by 91
The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool?
Xu, X., Jiang, L., Wu, C., Pan, L., Lou, Z., Peng, C., Dong, Y., & Ruan, B. (2021) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2021.07.013 · Cited by 88
PNPLA3—A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease
Dong, X. C. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00304 · Cited by 88
PPARs as Metabolic Sensors and Therapeutic Targets in Liver Diseases
Monroy-Ramírez, H. C., Galicia‐Moreno, M., Sandoval-Rodriguez, A. S., Meza-Ríos, A., Santos, A., & Armendáriz‐Borunda, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158298 · Cited by 86
Immunomodulatory nanosystems for treating inflammatory diseases
Ahamad, N., Kar, A., Mehta, S., Dewani, M., Ravichandran, V., Bhardwaj, P., Sharma, S., & Banerjee, R. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120875 · Cited by 88
Acrylamide-Induced Hepatotoxicity Through Oxidative Stress: Mechanisms and Interventions
Zhang, L., Yang, L., Luo, Y., Li, D., & Chen, F. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0055 · Cited by 89
The xenobiotic receptors PXR and CAR in liver physiology, an update
Cai, X., Young, G. M., & Xie, W. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166101 · Cited by 84
Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPARα to activate the NF-κB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance
Kong, L., Chen, J., Ji, X., Qin, Q., Yang, H., Liu, D., Li, D., & Sun, M. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01782-w · Cited by 82
S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent
Pascale, R. M., Simile, M. M., Calvisi, D. F., Feo, C. F., & Feo, F. (2022) · Cells · doi:10.3390/cells11030409 · Cited by 88
Oxidative stress in alcoholic liver disease, focusing on proteins, nucleic acids, and lipids: A review
Lai, W., Zhang, J., Sun, J., Min, T., Bai, Y., He, J., Cao, H., Che, Q., Guo, J., & Su, Z. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134809 · Cited by 89
Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis
Sehrawat, T. S., Arab, J. P., Liu, M., Amrollahi, P., Wan, M., Fan, J., Nakao, Y., Pose, E., Navarro‐Corcuera, A., Dasgupta, D., et al. (2020) · Hepatology · doi:10.1002/hep.31256 · Cited by 81
Self-citation
Cyanidin-3-O-β-glucoside inactivates NLRP3 inflammasome and alleviates alcoholic steatohepatitis via SirT1/NF-κB signaling pathway
Zhou, Y., Wang, S., Wan, T., Huang, Y., Pang, N., Jiang, X., Gu, Y., Zhang, Z., Luo, J., & Yang, L. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.08.006 · Cited by 79
Mitochondrial Dysfunction and Oxidative Stress in Liver Transplantation and Underlying Diseases: New Insights and Therapeutics
Shi, S., Wang, X., van der Laan, L. J. W., Pan, Q., & Verstegen, M. M. A. (2021) · Transplantation · doi:10.1097/tp.0000000000003691 · Cited by 85
Gut microbiota: A magical multifunctional target regulated by medicine food homology species
Zuo, W., Pang, Q., Yao, L.-P., Zhang, Y., Peng, C. Y., Huang, W., & Han, B. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.05.011 · Cited by 81
PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease
Lee, J. S., Mukhopadhyay, P., Mátyás, C., Trojnár, E., Pálóczi, J., Yang, Y. R., Blank, B. A., Savage, C. H., Sorokin, A. V., Mehta, N. N., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-53603-6 · Cited by 79
Sex differences in frailty among older adults
Zeidan, R. S., McElroy, T., Rathor, L., Martenson, M. S., Lin, Y., & Mankowski, R. T. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112333 · Cited by 79
Propionate Ameliorates Alcohol-Induced Liver Injury in Mice via the Gut–Liver Axis: Focus on the Improvement of Intestinal Permeability
Xu, Q., Zhang, R., Mu, Y., Song, Y., Hao, N., Wei, Y., Wang, Q., & Mackay, C. R. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c00633 · Cited by 76
Astragalus Polysaccharides and Saponins Alleviate Liver Injury and Regulate Gut Microbiota in Alcohol Liver Disease Mice
Zhou, J., Zhang, N., Zhao, L., Wu, W., Zhang, L., Zhou, F. L., & Li, J. (2021) · Foods · doi:10.3390/foods10112688 · Cited by 78
Structure and hepatoprotective activity of Usp10/NF-κB/Nrf2 pathway-related Morchella esculenta polysaccharide
Teng, S., Zhang, Y., Jin, X., Zhu, Y., Li, L., Huang, X., Wang, D., & Lin, Z. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.120453 · Cited by 76
The Role of the NLRP3 Inflammasome and Programmed Cell Death in Acute Liver Injury
Yu, C., Chen, P., Miao, L., & Di, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043067 · Cited by 85
Mitochondrial depolarization after acute ethanol treatment drives mitophagy in living mice
Samuvel, D. J., Li, L., Krishnasamy, Y., Gooz, M. B., Takemoto, K., Woster, P. M., Lemasters, J. J., & Zhong, Z. (2022) · Autophagy · doi:10.1080/15548627.2022.2046457 · Cited by 76
Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis
Huang, D. Q., Tan, D. J. H., Ng, C. H., Amangurbanova, M., Sutter, N., Tay, P. W. L., Lim, W. H., Yong, J. N., Tang, A. S. P., Syn, N. L. X., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.06.032 · Cited by 74
Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis
Chang, Y., Ryu, S., Kim, Y., Cho, Y. K., Sung, E., Kim, H., Ahn, J., Jung, H. S., Yun, K. E., Kim, S., et al. (2019) · Hepatology · doi:10.1002/hep.30867 · Cited by 74
Construction of a two-photon fluorescent probe for ratiometric imaging of hypochlorous acid in alcohol-induced liver injury
Lou, Y., Wang, C., Chi, S., Li, S., Mao, Z., & Liu, Z. (2019) · Chemical Communications · doi:10.1039/c9cc06888k · Cited by 72
Ferroptosis contributes to ethanol-induced hepatic cell death via labile iron accumulation and GPx4 inactivation
Luo, J., Song, G., Chen, N., Xie, M., Niu, X., Zhou, S., Ji, Y., Zhu, X., Ma, W., Zhang, Q., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01608-6 · Cited by 72
Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese Rats
Costa, M. R., Garcia, J. L., Silva, C. C. V. D. A., Ferron, A. J. T., Francisqueti‐Ferron, F. V., Hasimoto, F. K., Gregolin, C. S., de Campos, D. H. S., de Andrade, C. R., Ferreira, A. L. A., et al. (2019) · Antioxidants · doi:10.3390/antiox8080276 · Cited by 69
Aryl Hydrocarbon Receptor Deficiency in Intestinal Epithelial Cells Aggravates Alcohol-Related Liver Disease
Qian, M., Liu, J., Zhao, D., Cai, P., Pan, C., Jia, W., Gao, Y., Zhang, Y., Zhang, N., Zhang, Y., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.08.014 · Cited by 71
Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury
Liu, M., Huang, Q., Zhu, Y., Chen, L., Li, Y., Gong, Z., & Ai, K. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100215 · Cited by 70
Intercellular Communication between Hepatic Cells in Liver Diseases
Sato, K., Kennedy, L. L., Liangpunsakul, S., Kusumanchi, P., Yang, Z., Meng, F., Glaser, S. S., Francis, H., & Alpini, G. D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092180 · Cited by 73
Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy
Zhang, C., Liu, S., & Yang, M. J. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i2.180 · Cited by 73
Enhanced Ca2+-channeling complex formation at the ER-mitochondria interface underlies the pathogenesis of alcohol-associated liver disease
Thoudam, T., Chanda, D., Lee, J. Y., Jung, M., Sinam, I. S., Kim, B., Park, B.-Y., Kwon, W. H., Kim, H., Kim, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37214-4 · Cited by 74
Chlorogenic acids: A pharmacological systematic review on their hepatoprotective effects
Xue, H., Wei, M., & Ji, L. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154961 · Cited by 75

Authors: Seitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H.
Affiliations: Heidelberg University (DE)
University of Pittsburgh (US)
National Institutes of Health (US)
Hospital Clínic de Barcelona (ES)
Medical University of Graz (AT)
Inserm (FR)
University of Southern California (US)
ORCID: Bataller, Ramon
Gao, Bin
Gual, Antoni
Lackner, Carolin
Mathurin, Philippe
Mueller, Sebastian
Tsukamoto, Hidekazu
Venue: Nature Reviews Disease Primers
Publisher: Springer Science and Business Media LLC
Published: 2018-08-16
Volume: 4
Issue: 1
Pages: 16-16
ISSN: 2056-676X (ISSN-L)
DOI: 10.1038/s41572-018-0014-7
OpenAlex: W4210980460
Cited by: 1,271
References: 244
Citations by year: 2026: 126 · 2025: 200 · 2024: 249 · 2023: 230 · 2022: 176 · 2021: 145 · 2020: 75 · 2019: 57 · 2018: 9
FWCI: 10.57
Type: journal article
Language: en
Update notices: correction (2018-08-28)
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Disease Primers (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
Funders: U.S. Department of Veterans Affairs (IK6BX004205, I01 BX001991)
National Institute on Alcohol Abuse and Alcoholism (R01AA011576)
Topics: Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords: alcoholic liver disease, alcoholic fatty liver, alcoholic steatohepatitis, alcoholic hepatitis, liver cirrhosis, hepatocellular carcinoma, liver fibrosis, hepatic steatosis, oxidative stress, acetaldehyde toxicity, liver inflammation, alcoholism, liver fibrosis diagnosis, serum biomarkers, alcohol abstinence, liver transplantation
MeSH terms: Global Burden of Disease, Alcohol Drinking, Fatty Liver, Alcoholic, Humans, Liver Diseases, Alcoholic, Liver Neoplasms, Quality of Life, Liver Transplantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Alcoholic liver disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks